{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:36:36Z","timestamp":1789673796937,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":368,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2018YFA0507101"],"award-info":[{"award-number":["2018YFA0507101"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2021YFA1300301"],"award-info":[{"award-number":["2021YFA1300301"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["5212016"],"award-info":[{"award-number":["5212016"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ymthe.2023.11.019","type":"journal-article","created":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:27:29Z","timestamp":1700094449000},"page":"218-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["A cardiotoxicity-eliminated ACE2 variant as a pan-inhibitor against coronavirus cell invasion"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4504-3480","authenticated-orcid":false,"given":"Han","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linpu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongwan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7546-5609","authenticated-orcid":false,"given":"Eli","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2023.11.019_bib1","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s40262-013-0072-7","article-title":"Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects","volume":"52","author":"Haschke","year":"2013","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ymthe.2023.11.019_bib2","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/S2213-2600(20)30418-5","article-title":"Human recombinant soluble ACE2 in severe COVID-19","volume":"8","author":"Zoufaly","year":"2020","journal-title":"Lancet Resp Med."},{"key":"10.1016\/j.ymthe.2023.11.019_bib3","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1161\/HYPERTENSIONAHA.108.122333","article-title":"Onset of experimental severe cardiac fibrosis is mediated by overexpression of Angiotensin-converting enzyme 2","volume":"53","author":"Masson","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.ymthe.2023.11.019_bib4","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0022-2828(03)00177-9","article-title":"Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins","volume":"35","author":"Donoghue","year":"2003","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.ymthe.2023.11.019_bib5","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0735-1097(98)00317-9","article-title":"Effects of angiotensin II on expression of the gap junction channel protein connexin43 in neonatal rat ventricular myocytes","volume":"32","author":"Dodge","year":"1998","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.ymthe.2023.11.019_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.regpep.2007.12.006","article-title":"Opposite effects of angiotensin II and angiotensin (1-7) on impulse propagation, excitability and cardiac arrhythmias. Is the overexpression of ACE2 arrhythmogenic?","volume":"153","author":"De Mello","year":"2009","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ymthe.2023.11.019_bib7","doi-asserted-by":"crossref","first-page":"e01933-17","DOI":"10.1128\/JVI.01933-17","article-title":"Entry of Human Coronavirus NL63 into the Cell","volume":"92","author":"Milewska","year":"2018","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2023.11.019_bib8","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2023.11.019_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108427","article-title":"COVID-19 pathophysiology: A review","volume":"215","author":"Yuki","year":"2020","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.ymthe.2023.11.019_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2478\/jtim-2020-0003","article-title":"Potential Role of ACE2 in Coronavirus Disease 2019 (COVID-19) Prevention and Management","volume":"8","author":"Liu","year":"2020","journal-title":"J.\u00a0Transl. Int. Med."},{"key":"10.1016\/j.ymthe.2023.11.019_bib11","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2023.11.019_bib12","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/357420a0","article-title":"Human aminopeptidase N is a receptor for human coronavirus 229E","volume":"357","author":"Yeager","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2023.11.019_bib13","doi-asserted-by":"crossref","first-page":"452","DOI":"10.7883\/yoken.JJID.2016.106","article-title":"HeLa-ACE2-TMPRSS2 Cells Are Useful for the Isolation of Human Coronavirus 229E","volume":"69","author":"Matoba","year":"2016","journal-title":"Jpn. J. Infect. Dis."},{"key":"10.1016\/j.ymthe.2023.11.019_bib14","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41586-022-05513-3","article-title":"Close relatives of MERS-CoV in bats use ACE2 as their functional receptors","volume":"612","author":"Xiong","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2023.11.019_bib15","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/s41467-022-28528-w","article-title":"Structural basis for SARS-CoV-2 Delta variant recognition of ACE2 receptor and broadly neutralizing antibodies","volume":"13","author":"Wang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2023.11.019_bib16","doi-asserted-by":"crossref","first-page":"8540","DOI":"10.1038\/s41598-022-12479-9","article-title":"Assessment of mutations on RBD in the Spike protein of SARS-CoV-2 Alpha, Delta and Omicron variants","volume":"12","author":"da Costa","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2023.11.019_bib17","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1111\/j.1742-4658.2005.04756.x","article-title":"Identification of critical active-site residues in angiotensin-converting enzyme-2 (ACE2) by site-directed mutagenesis","volume":"272","author":"Guy","year":"2005","journal-title":"FEBS J."},{"key":"10.1016\/j.ymthe.2023.11.019_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.809244","article-title":"SARS-CoV-2 Variants, Vaccines, and Host Immunity","volume":"12","author":"Mistry","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2023.11.019_bib19","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.2174\/1381612828666220701160116","article-title":"COVID-19 Challenge: A Quest for Effective Vaccine Strategies Against Circulating and Emerging SARS-CoV-2 Variants","volume":"28","author":"Yogesh","year":"2022","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ymthe.2023.11.019_bib20","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.3390\/ijms22031308","article-title":"The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis","volume":"22","author":"Wong","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2023.11.019_bib21","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1080\/14760584.2022.2110075","article-title":"Vaccines against SARS-CoV-2 variants and future pandemics","volume":"21","author":"Park","year":"2022","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.ymthe.2023.11.019_bib22","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.stemcr.2020.12.010","article-title":"Broad-Spectrum Anti-coronavirus Vaccines and Therapeutics to Combat the Current COVID-19 Pandemic and Future Coronavirus Disease Outbreaks","volume":"16","author":"Cao","year":"2021","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.ymthe.2023.11.019_bib23","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00408-020-00408-4","article-title":"ACE2: The Major Cell Entry Receptor for SARS-CoV-2","volume":"198","author":"Scialo","year":"2020","journal-title":"Lung"},{"key":"10.1016\/j.ymthe.2023.11.019_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2022.901244","article-title":"Resilience and Protection of Health Care and Research Laboratory Workers During the SARS-CoV-2 Pandemic: Analysis and Case Study From an Austrian High Security Laboratory","volume":"13","author":"Loibner","year":"2022","journal-title":"Front. Psychol."},{"key":"10.1016\/j.ymthe.2023.11.019_bib25","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.3390\/microorganisms9102167","article-title":"Severity, Pathogenicity and Transmissibility of Delta and Lambda Variants of SARS-CoV-2, Toxicity of Spike Protein and Possibilities for Future Prevention of COVID-19","volume":"9","author":"Moghaddar","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.ymthe.2023.11.019_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2021.152345","article-title":"Toxicity of spike fragments SARS-CoV-2\u00a0S protein for zebrafish: A tool to study its hazardous for human health?","volume":"813","author":"Ventura Fernandes","year":"2022","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.ymthe.2023.11.019_bib27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41392-021-00821-y","article-title":"A binding-enhanced but enzymatic activity-eliminated human\u00a0ACE2 efficiently neutralizes SARS-CoV-2 variants","volume":"7","author":"Zheng","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2023.11.019_bib28","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.coph.2010.12.002","article-title":"ACE2, a promising therapeutic target for pulmonary hypertension","volume":"11","author":"Shenoy","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ymthe.2023.11.019_bib29","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00109-012-0859-2","article-title":"Angiotensin converting enzyme 2 abrogates bleomycin-induced lung injury","volume":"90","author":"Rey-Parra","year":"2012","journal-title":"J.\u00a0Mol. Med. (Berl)"},{"key":"10.1016\/j.ymthe.2023.11.019_bib30","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1165\/rcmb.2012-0451OC","article-title":"Angiotensin-converting enzyme 2\/angiotensin-(1-7)\/Mas axis protects against lung fibrosis by inhibiting the MAPK\/NF-kappaB pathway","volume":"50","author":"Meng","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ymthe.2023.11.019_bib31","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejim.2020.04.037","article-title":"The pivotal link between ACE2 deficiency and SARS-CoV-2 infection","volume":"76","author":"Verdecchia","year":"2020","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.ymthe.2023.11.019_bib32","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","article-title":"Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2","volume":"181","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2023.11.019_bib33","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/s41423-020-0458-z","article-title":"Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies","volume":"17","author":"Yi","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ymthe.2023.11.019_bib34","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.05035-22","article-title":"Oral Administration of Universal Bacterium-Vectored Nucleocapsid-Expressing COVID-19 Vaccine is Efficacious in Hamsters","volume":"11","author":"Jia","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.ymthe.2023.11.019_bib35","article-title":"Antiviral T-cell Biofactory platform for SARS-CoV-2","author":"Ssemadaali","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.ymthe.2023.11.019_bib36","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1021\/acs.bioconjchem.1c00013","article-title":"Triton X-114 and Amine-Based Wash Strategy Reduces Lipopolysaccharides to FDA Limit and Achieves Purer, More Potent Recombinant Immunotoxin","volume":"32","author":"George","year":"2021","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ymthe.2023.11.019_bib37","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.049632","article-title":"Comparison of the pathogenesis of SARS-CoV-2 infection in K18-hACE2 mouse and Syrian golden hamster models","volume":"15","author":"Jeong","year":"2022","journal-title":"Dis. Model Mech."},{"key":"10.1016\/j.ymthe.2023.11.019_bib38","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s41048-015-0008-x","article-title":"An efficient two-step subcellular fractionation method for the enrichment of insulin granules from INS-1 cells","volume":"1","author":"Chen","year":"2015","journal-title":"Biophys. Rep."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001623006202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001623006202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T01:34:18Z","timestamp":1736300058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001623006202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1525001623006202"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2023.11.019","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A cardiotoxicity-eliminated ACE2 variant as a pan-inhibitor against coronavirus cell invasion","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2023.11.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}